Protalix BioTherapeutics (PLX) Exchange Rate Effect (2010 - 2026)
Protalix BioTherapeutics (PLX) recorded quarterly Exchange Rate Effect of -$77000.0 in Q1 2026, down 148.39% quarter-over-quarter from -$31000.0 in Q4 2025, and down 862.5% on a YoY basis from $10098.4 in Q1 2025.
Protalix BioTherapeutics (PLX) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics' Exchange Rate Effect history runs 17 years deep, the most recent figure standing at -$77000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 862.5% year-over-year to -$77000.0; the TTM figure through Mar 2026 stood at -$116000.0 (down 583.33% YoY), while the FY2025 annual figure was -$47000.0, down 288.0% from the prior year.
- Exchange Rate Effect was -$77000.0 for Q1 2026 at Protalix BioTherapeutics, down from -$31000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $54000.0 in Q4 2024 to a low of -$77000.0 in Q1 2026.
- Historically, Exchange Rate Effect has averaged -$18125.0 across 5 years, with a median of -$16000.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect tumbled 900.0% in 2022, then jumped 300.0% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at -$26000.0 in 2022, then slipped by 3.85% to -$27000.0 in 2023, then surged by 300.0% to $54000.0 in 2024, then tumbled by 157.41% to -$31000.0 in 2025, then slumped by 148.39% to -$77000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$77000.0 (Q1 2026), -$31000.0 (Q4 2025), and -$12000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Protalix BioTherapeutics | 176.47 Mn | 165.67 Mn | 29.62 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,000.00 |
| Mar 31, 2026 | -77,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Dec 31, 2023 | -27,000.00 |